Table 1 Clinical features of included participants in CS08
Patient ID | Age (yrs) | Gender | Diagnosis | Spherical power (D) | BCVA | ||
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | O.D | O.S | O.D | O.S |
II:1 | 63 | M | IXT | – 0.50 | – 0.50 | 0.6 | 0.6 |
II:8 | 58 | F | IXT | 0 | – 0.50 | 1.0 | 1.0 |
II:12 | 55 | M | IXT | 0 | – 0.25 | 1.0 | 0.6 |
III:1 | 42 | M | IXT | – 1.00 | – 0.75 | 1.0 | 1.0 |
III:6 | 33 | F | CXT | – 3.00 | – 2.50 | 0.6 | 1.0 |
III:9 | 39 | F | IXT | – 1.25 | – 1.00 | 1.0 | 0.8 |
III:12 | 36 | M | NOR | 0 |  + 0.25 | 1.0 | 1.0 |
III:14 | 34 | M | IXT | – 3.35 | – 3.50 | 1.0 | 1.0 |
III:17 | 26 | F | IXT | – 3.25 | – 3.50 | 1.0 | 1.0 |
III:19 | 22 | F | IXT | 0 |  + 1.00 | 1.0 | 1.0 |
IV:1 | 19 | F | IXT | – 3.00 | – 3.00 | 1.0 | 1.0 |
IV:3 | 18 | F | NOR | – 2.00 | – 1.50 | 0.8 | 1.0 |
IV:4 | 14 | M | IXT | – 5.00 | – 5.00 | 1.0 | 1.0 |
IV:5 | 9 | F | IXT | – 1.25 | – 1.00 | 1.0 | 1.0 |